Kidswell Bio Corporation (TYO:4584)

Kidswell Bio Statistics

Total Valuation

Kidswell Bio has a market cap or net worth of JPY 13.59 billion. The enterprise value is 12.43 billion.

Market Cap	13.59B
Enterprise Value	12.43B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Kidswell Bio has 49.61 million shares outstanding. The number of shares has increased by 57.77% in one year.

Current Share Class	49.61M
Shares Outstanding	49.61M
Shares Change (YoY)	+57.77%
Shares Change (QoQ)	+2.18%
Owned by Insiders (%)	5.07%
Owned by Institutions (%)	-6.07%
Float	34.91M

Valuation Ratios

The trailing PE ratio is 567.06 and the forward PE ratio is 16.07.

PE Ratio	567.06
Forward PE	16.07
PS Ratio	1.92
PB Ratio	7.06
P/TBV Ratio	7.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	518.67
EV / Sales	1.76
EV / EBITDA	n/a
EV / EBIT	49.74
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.07, with a Debt / Equity ratio of 1.36.

Current Ratio	3.07
Quick Ratio	2.15
Debt / Equity	1.36
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	6.65

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	19.65%
Return on Capital Employed (ROCE)	5.76%
Weighted Average Cost of Capital (WACC)	9.51%
Revenue Per Employee	190.93M
Profits Per Employee	647,892
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Kidswell Bio has paid 58.81 million in taxes.

Income Tax	58.81M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +112.40% in the last 52 weeks. The beta is 1.25, so Kidswell Bio's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	+112.40%
50-Day Moving Average	246.34
200-Day Moving Average	251.48
Relative Strength Index (RSI)	56.74
Average Volume (20 Days)	1,532,320

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kidswell Bio had revenue of JPY 7.06 billion and earned 23.97 million in profits. Earnings per share was 0.51.

Revenue	7.06B
Gross Profit	1.73B
Operating Income	249.98M
Pretax Income	82.78M
Net Income	23.97M
EBITDA	n/a
EBIT	249.98M
Earnings Per Share (EPS)	0.51

Balance Sheet

The company has 3.78 billion in cash and 2.63 billion in debt, with a net cash position of 1.16 billion or 23.38 per share.

Cash & Cash Equivalents	3.78B
Total Debt	2.63B
Net Cash	1.16B
Net Cash Per Share	23.38
Equity (Book Value)	1.93B
Book Value Per Share	38.83
Working Capital	4.09B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	3.54%
Pretax Margin	1.17%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Kidswell Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.77%
Shareholder Yield	-57.77%
Earnings Yield	0.18%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 27, 2018. It was a forward split with a ratio of 2.

Last Split Date	Jun 27, 2018
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	1